---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-24-000063"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:34:39.671228+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics annual meeting adjourned due to lack of quorum; reconvened Nov 21

## Summary
- Virtual annual meeting on Nov 7, 2024 lacked a quorum of common stock holders.
- Meeting adjourned to Nov 21, 2024 at 9:30 a.m. ET; no in-person attendance.
- Existing proxies remain valid; new proxy voting deadline is Nov 20, 2024 11:59 p.m. ET.
- Record date remains Sept 11, 2024; preregistered stockholders need not re-register.
- Majority of received proxies voted in favor of all proposals.

## SEC filing metadata
- accession: 0001601485-24-000063
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000063/0001601485-24-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000063/angn-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-24-000063
- JSON: https://secwatch.observer/filing/0001601485-24-000063.json
- Plain text: https://secwatch.observer/filing/0001601485-24-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.